FN Media Group Presents USA News Group News Commentary VANCOUVER, BC, April 11, 2024 /PRNewswire/ — USA News Group – The…
Tuesday, YS Biopharma Co Ltd YS revealed interim results from the ongoing Phase 3 clinical trial of its next-generation PIKA Rabies Vaccine. The…
Source: PopTika / Shutterstock.com It is not a bad idea to hunt for biotech stocks to sell. Such stocks have…
Friday, the FDA approved Johnson & Johnson JNJ Carvykti (ciltacabtagene autoleucel; cilta-cel) for relapsed or refractory multiple myeloma patients who have received…
With the market off to a rather wobbly start to the second quarter of 2024, investors may be looking for…
Morgan Stanley’s analysis of historical data suggests that potential Federal Reserve rate cut(s) should have a favorable impact on Biotech…
By Karen Freifeld (Reuters) – A Republican and a Democratic member of Congress are calling on the Biden administration to…
Stephen C. Glover, co-founder, chairman, CEO and president of ZyVersa Therapeutics Inc. ZVSA, was recently a panelist at Biedex Markets’s…
Marc Hedrick, President & CEO of Plus Therapeutics PSTV, recently presented at Biedex Markets’s Virtual HealthCare Summit 2024. Plus Therapeutics…
The U.S. Patent and Trademark Office (USPTO) has granted PharmAla Biotech Holdings MDXXF a national patent covering the composition of…